Qualigen Therapeutics Stock Market Value
| QLGN Stock | USD 4.83 0.41 9.28% |
| Symbol | Qualigen |
Qualigen Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Qualigen Therapeutics. If investors know Qualigen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Qualigen Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 3.6 K | Revenue Per Share 1.034 | Quarterly Revenue Growth 0.137 | Return On Assets (0.75) | Return On Equity (8.42) |
The market value of Qualigen Therapeutics is measured differently than its book value, which is the value of Qualigen that is recorded on the company's balance sheet. Investors also form their own opinion of Qualigen Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Qualigen Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Qualigen Therapeutics' market value can be influenced by many factors that don't directly affect Qualigen Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Qualigen Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Qualigen Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Qualigen Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Qualigen Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Qualigen Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Qualigen Therapeutics.
| 02/27/2024 |
| 11/23/2024 |
If you would invest 0.00 in Qualigen Therapeutics on February 27, 2024 and sell it all today you would earn a total of 0.00 from holding Qualigen Therapeutics or generate 0.0% return on investment in Qualigen Therapeutics over 270 days. Qualigen Therapeutics is related to or competes with ZyVersa Therapeutics, Immix Biopharma, Phio Pharmaceuticals, 180 Life, Entera Bio, Anebulo Pharmaceuticals, and Indaptus Therapeutics. Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer an... More
Qualigen Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Qualigen Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Qualigen Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 47.03 | |||
| Value At Risk | (10.06) | |||
| Potential Upside | 9.21 |
Qualigen Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Qualigen Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Qualigen Therapeutics' standard deviation. In reality, there are many statistical measures that can use Qualigen Therapeutics historical prices to predict the future Qualigen Therapeutics' volatility.| Risk Adjusted Performance | (0.1) | |||
| Jensen Alpha | (1.01) | |||
| Total Risk Alpha | (1.98) | |||
| Treynor Ratio | (1.28) |
Qualigen Therapeutics Backtested Returns
Qualigen Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of -0.13, which implies the firm had a -0.13% return per unit of risk over the last 3 months. Qualigen Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Qualigen Therapeutics' Variance of 45.11, coefficient of variation of (737.80), and Risk Adjusted Performance of (0.1) to confirm the risk estimate we provide. The company holds a Beta of 0.72, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Qualigen Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Qualigen Therapeutics is expected to be smaller as well. At this point, Qualigen Therapeutics has a negative expected return of -0.87%. Please make sure to check Qualigen Therapeutics' treynor ratio, as well as the relationship between the kurtosis and day typical price , to decide if Qualigen Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.84 |
Very good predictability
Qualigen Therapeutics has very good predictability. Overlapping area represents the amount of predictability between Qualigen Therapeutics time series from 27th of February 2024 to 11th of July 2024 and 11th of July 2024 to 23rd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Qualigen Therapeutics price movement. The serial correlation of 0.84 indicates that around 84.0% of current Qualigen Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.84 | |
| Spearman Rank Test | 0.89 | |
| Residual Average | 0.0 | |
| Price Variance | 10.29 |
Qualigen Therapeutics lagged returns against current returns
Autocorrelation, which is Qualigen Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Qualigen Therapeutics' stock expected returns. We can calculate the autocorrelation of Qualigen Therapeutics returns to help us make a trade decision. For example, suppose you find that Qualigen Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Qualigen Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Qualigen Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Qualigen Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Qualigen Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Qualigen Therapeutics Lagged Returns
When evaluating Qualigen Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Qualigen Therapeutics stock have on its future price. Qualigen Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Qualigen Therapeutics autocorrelation shows the relationship between Qualigen Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Qualigen Therapeutics.
Regressed Prices |
| Timeline |
Pair Trading with Qualigen Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Qualigen Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Qualigen Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Qualigen Stock
| 0.68 | A | Agilent Technologies Earnings Call This Week | PairCorr |
| 0.8 | ME | 23Andme Holding | PairCorr |
| 0.73 | VALN | Valneva SE ADR | PairCorr |
| 0.8 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
Moving against Qualigen Stock
| 0.71 | MDGL | Madrigal Pharmaceuticals | PairCorr |
| 0.46 | RNXT | RenovoRx | PairCorr |
| 0.36 | NXGLW | NexGel Warrant | PairCorr |
| 0.35 | KZR | Kezar Life Sciences | PairCorr |
| 0.34 | KEP | Korea Electric Power | PairCorr |
The ability to find closely correlated positions to Qualigen Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Qualigen Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Qualigen Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Qualigen Therapeutics to buy it.
The correlation of Qualigen Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Qualigen Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Qualigen Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Qualigen Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Qualigen Therapeutics Correlation, Qualigen Therapeutics Volatility and Qualigen Therapeutics Alpha and Beta module to complement your research on Qualigen Therapeutics. To learn how to invest in Qualigen Stock, please use our How to Invest in Qualigen Therapeutics guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Qualigen Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.